Clinical Trial Update: OPTImization of the Dose of tacroliMUS by Bayesian Prediction [Phase 4]

View source ↗

Summary

Phase 4 trial updating optimal tacroliMUS dosing using Bayesian prediction in kidney transplant patients has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Kidney Transplantation

Drugs mentioned

• Tacrolimus (Tacrolimus)

Snippet

Sponsor: NURIA LLOBERAS BLANCH | Conditions: KIDNEY TRANSPLANTATION | Phase 4 | Status: COMPLETED